OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164,360 | -34.0% | 52,344 | +8.4% | 0.00% | -100.0% |
| Q2 2023 | $249,135 | +193.4% | 48,282 | +199.6% | 0.00% | – |
| Q1 2023 | $84,921 | +20.9% | 16,114 | -35.5% | 0.00% | – |
| Q4 2022 | $70,225 | -5.1% | 24,991 | +35.4% | 0.00% | – |
| Q2 2022 | $74,000 | -2.6% | 18,459 | +69.2% | 0.00% | – |
| Q4 2021 | $76,000 | -72.3% | 10,912 | -34.7% | 0.00% | -100.0% |
| Q1 2021 | $274,000 | -66.6% | 16,704 | -80.3% | 0.00% | -80.0% |
| Q1 2016 | $821,000 | – | 85,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |